CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Cash flows from operating activities:
Net income	$ 2,184	$ 8,612
Adjustments to reconcile net income to net cash from operating activities:
Depreciation	7,367	6,850
Amortization of purchased intangible assets	9,526	10,599
Amortization of deferred debt issuance costs	448	407
Stock-based compensation	3,016	3,331
Bad debt expense	696	1,036
Deferred income taxes	414	(1,292)
Asset impairments	296	0
Other	988	(788)
Change in:
Accounts receivable, net	(4,854)	(13,903)
Inventories	10,716	(8,835)
Prepaid expenses and other	12,367	2,677
Accounts payable	(4,449)	22,070
Contract liabilities	(11,415)	(5,135)
Accrued expenses and other liabilities	(7,566)	(9,846)
Net cash provided by operating activities	19,734	15,783
Cash flows from investing activities:
Proceeds from maturities of marketable securities	0	3,000
Proceeds from sales of marketable securities	0	9,619
Acquisition of property, plant and equipment	(6,700)	(5,515)
Proceeds from property, plant and equipment reimbursements	1,788	0
Proceeds on sale of property, plant and equipment	27	100
Proceeds from settlement of note receivable	4,167	0
Net cash (used in) provided by investing activities	(718)	7,204
Cash flows from financing activities:
Repayments on term loan	(1,250)	(118,125)
Borrowings on term loan	0	50,000
Borrowings on revolving loans	46,859	77,150
Repayments on revolving loans	(57,887)	(40,525)
Payment of debt issuance costs	(650)	(2,735)
Distributions to redeemable noncontrolling interest holder	(6,255)	(4,672)
Net proceeds from issuance of common stock to employees and directors	0	132
Treasury stock purchases	(563)	(952)
Net cash used in financing activities	(19,746)	(39,727)
Effects of exchange rates on cash	(1,132)	267
Net decrease in cash and cash equivalents	(1,862)	(16,473)
Cash and cash equivalents, beginning of the period	14,289	31,040
Cash and cash equivalents, end of the period	$ 12,427	$ 14,567